KAIST Team
Dong Soo Yang – PostDoc Researcher
Email: [email protected]
Dongsoo Yang, postdoctoral researcher at KAIST Department of Chemical and Biomolecular Engineering (PI Dr. Sang Yup Lee), was appointed as an assistant professor at Korea University Department of Chemical and Biological Engineering, starting from September. Dongsoo Yang was a postdoctoral researcher in Korea Advanced Institute of Science and Technology (KAIST), South Korea under the supervision of Prof. Sang Yup Lee. He earned his B.S. degree in the same institution, KAIST, with chemical and biomolecular engineering major and chemistry minor. He also earned his Ph.D. degree in KAIST under the supervision of Professor Sang Yup Lee, with the thesis titled “Development of systems metabolic engineering tools and strategies and their applications on microbial production of natural compounds”. His research field lies in metabolic engineering, systems biology and synthetic biology. His current studies are focused on developing various metabolic engineering and synthetic biology tools including small regulatory RNAs for heterologous production of medicinal secondary metabolites in Escherichia coli. In the IIMENA team, he will be taking part in developing robust bacterial hosts including E. coli for efficient heterologous production of novel antibiotics.
Kyeong Rok Choi – Assistant Research Professor
Email: [email protected]
Kyeong Rok Choi is an assistant research professor in BioProcess Engineering Research Center at Korea Advanced Institute of Science and Technology (KAIST). He develops synthetic biology tools for efficient bacterial strain development. Applying the new tools developed, he engineers microorganisms producing value-added chemicals from renewable carbon sources, combining disciplines of metabolic engineering and synthetic biology. Previously, he metabolically engineered bacteria for the production of valuable chemicals and developed biological method for the production of metallic nanoparticles (e.g. quantum dots), as a researcher in MBEL. He was actively involved in developing synthetic single-copy genetic circuit in Collins lab at Boston University (currently at MIT) and developing drug combination therapy for ovarian cancer treatment in Hasan lab at Wellman Center for Photomedicine at Massachusetts General Hospital, as an intern. Elucidation of cell aggregation mechanism in a photoautotrophic bacterium is another research theme he devoted to. He conducted doctoral research at Metabolic and Biomolecular Engineering National Research Laboratory (MBEL) under the advice of Prof. Sang Yup Lee at KAIST. He double majored in chemical & biomolecular engineering and biological sciences at KAIST. In the IIMENA team, he will be taking part of developing of bacterial genome engineering tools, DNA manipulation tools for BCGs and bacterial strains (including E. coli) producing new antibiotics.
Dahyeon Park – Graduated PhD Student
Email: [email protected]
Dahyeon Park graduated from Prof. Sang Yup Lee’s lab at KAIST, and therefore we would like to thank him for his contribution to the project. His major tasks was developing advanced genome engineering tools in various bacterial species, mostly focused on Pseudomonas sp., in IIMENA team.
Mohammad Rifqi Ghiffary – PhD Student
Email: [email protected]
Mohammad Rifqi Ghiffary is a PhD student in Systems Biology and Medicine Laboratory (SBML) at Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST) under the supervision of Prof. Hyun Uk Kim. He received his bachelor degree in Bioengineering in 2015 from Institut Teknologi Bandung (ITB), Indonesia and his master in Biotechnology at Wageningen University and Research (WUR), The Netherlands. During his master study, he worked on developing genome engineering techniques (CRISPR-Cas systems) as efficient tools for bacterial metabolic engineering, supervised by Spinoza laureate Prof. John van der Oost. In the IIMENA team, he takes a part in heterologous production of secondary metabolites derived from actinomycetes and developing robust molecular tools for bacterial genome editing.